Pharmacy

Azopt Eye Drops Generic Brinzolamide

Home » Prescription Drugs 2 » Azopt Eye Drops Generic Brinzolamide

AZOPT Eye Drops contain the active ingredient brinzolamide which belongs to a class of medicines known as "carbonic anhydrase inhibitors".AZOPT Eye Drops are used either alone or in combination with other eye drops/medicines to lower raised pressure in the eye and to treat glaucoma.Glaucoma is usually caused by a build up of the fluid which flows through the eye leading to an increase in the pressure within the eye; some people with glaucoma may however have normal pressure within the eye.AZOPT Eye Drops lower the pressure within the eye by reducing the production of fluid.Although AZOPT Eye Drops help to control your glaucoma they do not cure it.AZOPT Eye Drops are not addictive.

Buy Azopt Eye Drops Generic Brinzolamide and other Prescription Drugs 2 products online at Medstore.

Buy Online at Medstore - Click Here!

About Azopt Eye Drops Generic Brinzolamide:

Product Type: Prescription Drugs 2

Azopt Eye Drops ( Generic Brinzolamide ) Product Origin: United Kingdom

Azopt Eye Drops (Generic Brinzolamide)

Generic Brinzolamide

1%w/v Generic Brinzolamide Azopt Eye Drops

View more Prescription Drugs 2

Previous Product  Next Product

Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.